Alkem Laboratories Limited Share Price Today
Techno Funda Ratings
Key Metrics
Current Price
₹5563Market Cap
₹ 66,578 Cr.Stock P/E
27.3ROE
18.9 %RSI
43.5Trend
BullishShare Price Chart
Technical Commentary
Buy or Sell Analysis
Company Overview
Alkem Laboratories is engaged in pharmaceutical business with global operations. The Company is engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products.(Source : 202003-01 Annual Report Page No:107)
Alkem Laboratories Ltd share price remains one of the actively tracked stocks on NSE among traders and long term investors.
The latest Alkem Laboratories Ltd share price NSE movement reflects ongoing investor interest driven by company fundamentals, sector performance and broader market sentiment.
From a technical analysis perspective, the Alkem Laboratories Ltd share price chart currently indicates a Bullish trend based on moving averages and RSI momentum analysis.
Technical Analysis
| Indicator | Value |
|---|---|
| Current Price | 5563 |
| RSI (14) | 43.5 |
| 50 DMA | 5455.84 |
| 200 DMA | 5532.45 |
| Trend | Bullish |
| A/D Rating | B |
| RS Rating | 52 |
| EPS Rating | 40 |
| TI65 | 1.03 |
| TI65 Trend | Neutral |
Pivot Points Analysis
Daily pivot points for Alkem Laboratories Limited calculated using previous trading session data. These levels help traders identify intraday support, resistance and breakout zones using Classic Pivot Point methodology.
Classic Pivot Points
| Level | Value |
|---|---|
| R3 | ₹5838.34 |
| R2 | ₹5773.67 |
| R1 | ₹5668.34 |
| PP | ₹5603.67 |
| S1 | ₹5498.34 |
| S2 | ₹5433.67 |
| S3 | ₹5328.34 |
Financial Ratios
| Metric | Value |
|---|---|
| Market Cap | ₹ 66,578 Cr. |
| Current Price | ₹ 5,563 |
| High / Low | ₹ 5,934 / 4,738 |
| Stock P/E | 27.3 |
| Book Value | ₹ 1,156 |
| Dividend Yield | 0.81 % |
| ROCE | 21.2 % |
| ROE | 18.9 % |
| Face Value | ₹ 2.00 |
Quarterly Results
| Quarter | Sales | Profit | OPM |
|---|---|---|---|
| Mar 2023 | 2,903 | 68 | 12% |
| Jun 2023 | 2,968 | 288 | 13% |
| Sep 2023 | 3,440 | 615 | 22% |
| Dec 2023 | 3,324 | 604 | 21% |
| Mar 2024 | 2,936 | 304 | 14% |
| Jun 2024 | 3,032 | 550 | 20% |
| Sep 2024 | 3,415 | 702 | 22% |
| Dec 2024 | 3,374 | 641 | 23% |
| Mar 2025 | 3,144 | 322 | 12% |
| Jun 2025 | 3,371 | 668 | 22% |
| Sep 2025 | 4,001 | 779 | 23% |
| Dec 2025 | 3,737 | 653 | 22% |
| Mar 2026 | 3,603 | 251 | 14% |
Shareholding Pattern
| Holder | Holding |
|---|---|
| Promoters | 66.97% |
| FIIs | 4.22% |
| DIIs | 2.53% |
| Public | 26.28% |
| No. of Shareholders | 67,050 |
| Government | 0.00% |
Pros and Cons
Pros
- Healthy return on equity of 18.9% indicating strong capital allocation efficiency.
- Strong technical momentum with price holding comfortably above the 50 DMA (5455.84).
Cons
Related NSE Stocks
SRF Limited
View Share Price Analysis →Coromandel International Limited
View Share Price Analysis →Gujarat Mineral Development Corporation Limited
View Share Price Analysis →Zydus Lifesciences Limited
View Share Price Analysis →Supreme Industries Limited
View Share Price Analysis →Angel One Limited
View Share Price Analysis →JK Cement Limited
View Share Price Analysis →Acme Solar Holdings Limited
View Share Price Analysis →L&T Finance Limited
View Share Price Analysis →Asahi India Glass Limited
View Share Price Analysis →CESC Limited
View Share Price Analysis →Oberoi Realty Limited
View Share Price Analysis →Frequently Asked Questions
What is the current technical trend and RSI for Alkem Laboratories Ltd share?
Based on the latest closing data, the technical momentum for Alkem Laboratories Ltd is currently evaluated as Bullish. The stock is exhibiting an RSI (14) of 43.5, indicating it is trading in a neutral balanced zone. Key tracking supports are currently located near the daily pivots, with price relative to the 50 DMA (5455.84) defining immediate multi-day trend patterns.
What are the key resistance and support pivot points for Alkem Laboratories Ltd?
According to Classic Pivot Point methodologies, the core trading floor for Alkem Laboratories Ltd today centers at a Pivot Point (PP) of ₹5603.67. Upside resistance challenges are calculated at R1: ₹5668.34, R2: ₹5773.67, and R3: ₹5838.34. Conversely, if selling pressure intensifies, immediate floor support targets are positioned at S1: ₹5498.34, S2: ₹5433.67, and S3: ₹5328.34.
How does the fundamental ROE and P/E ratio look for Alkem Laboratories Ltd?
Alkem Laboratories Ltd is currently trading with a valuation metrics context of a Stock P/E of 27.3, against a core structural efficiency Return on Equity (ROE) standing at 18.9 %. This fundamental operational efficiency baseline is coupled with an EPS Rating of 41, allowing investors to track how corporate profitability trends align with current price discovery cycles on the National Stock Exchange (NSE).
Should I buy or sell Alkem Laboratories Ltd shares based on corporate rankings?
Our dynamic trade matrix suggests a status of: Speculative Momentum Phase (Neutral / Hold). Alkem Laboratories Ltd is trading a... For long-term portfolios, decision-making should match the stock's market performance profile, which currently displays an institutional Accumulation/Distribution (A/D) grade of B, a Relative Strength (RS) ranking of 55, and long-term trend backing from the TI65 indicator (Neutral pattern).